Interaction of retinoic acid and interferon-α in breast cancer cell lines

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 369-374

  Widschwendter, Martin ^a   Daxenbichler, Günter ^a   Bachmair, Franz ^a   Müller, Elisabeth ^a   Zeimet, Alain G ^a   Windbichler, Gudrun ^a   Uhl Steidl, Michael ^a   Lang, Thomas ^a   Marth, Christian ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Breast cancer; Interaction; Interferon; Proliferation inhibition; Retinoic acid

Indexed keywords

ALPHA INTERFERON; CYTOKINE; KERATOLYTIC AGENT; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL DIVISION; DRUG INTERACTIONS; HUMANS; INTERFERON TYPE I, RECOMBINANT; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0029986599     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Marth C, Daxenbichler G and Dapunt O: Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. J Natl Cancer Inst 77: 1197-1202, 1986.
2. Wuarin L, Verity MA and Sidell N: Effects of interferon-gamma and its interaction with retinoic acid on human neuroblastoma differentiation. Int J Cancer 48. 136-141, 1991.
3. Majewski S, Szmurlo A, Marczak M, Jablonska S, and Botlag W: Synergistic effect of retinoids and interferon α on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor cell lines. Int J Cancer, 57: 81-85, 1994.
4. Petkovich M. Regulation of gene expression by Vitamin A: The role of nuclear retinoic acid receptors. Annu Rev Nutr 12: 443-471, 1992.
5. Aguet M, Dembric Z and Merlin G: Molecular cloning and expression of the human Interferon-gamma receptor. Cell 55: 273-280, 1988.
6. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueno F, Paredes-Casillas P, Hong WK, Holdener E and Krakoff IH: 13-cis retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84: 241-245, 1992.
7. Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU and Hong WK: 13-cis retinoic acid and interferon a-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84: 235-241, 1992.
8. Kudelka AP, Freedman RS, Edwards CL, Lippman SM, Tomos CS, Krakoff IH and Kavanagh JJ: Metastatic adenocarcinoma of the endometrium treated with 13-cis-retmoic acid plus interferon-α. Anti Cancer Drugs 4: 335-337, 1993.
9. Widschwendter M, Daxenbichler G, Dapunt O and Marth C: Effects of retinoic acid and interferon-γ on expression of retinoic acid receptor and cellular retinoic acid binding protein in breast cancer cells. Cancer Res 55: 2135-2139, 1995.
10. Marth C, Zech J, Bock G, Mayer I and Daxenbichler G: Effects of retinoids and interferon-gamma on cultured breast cancer cells in comparison with tumor necrosis factor alpha. Int J Cancer 40: 840-845, 1987.
11. Brand N, Petkovich M, Krust A, Chambon P, de The H, Marchio A, Tiollaia P and Dejean A: Identification of a second human retinoic acid receptor. Nature 332: 850-853, 1988.
12. Krust A, Kastner P, Petkovich M, Zelent A and Chambon P: A third human retinoic acid receptor, hRAR-γ. Proc Natl Acad Sci USA 86: 5310-5314, 1989.
13. Astrom A, Tavakkol A, Pettersson U, Cromie M, Elder JT and Voorhees JJ: Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). J Biol Chem 266: 17662-17666, 1991.
14. Hamada K, Gleason SL, Levi BZ, Hirschfeld S, Appella E and Ozato K: H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class 1 genes and the estrogen response element. Proc Natl Acad Sci USA 86: 8289-8293, 1989.
15. Sachs L: Angewandte Statistik., Springer, Berlin, Heidelberg, New York, pp 380-392, 1992.
16. Marth C, Widschwendter M and Daxenbichler G: Mechanism of synergistic action of all-trans- or 9-cis-retinoic acid and interferons in breast cancer cells. J Steroid Biochem Molec Biol 47: 123-126, 1993.
17. Roman SD, Ormandy CJ, Manning D, Blamey RW, Nicholson RI, Sutherland RL and Clarke, CL: Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res 53: 5940-5945, 1994.
18. de Thé H, Marchio A, Tiollais P and Dejean A: Differential expression and ligand regulation of the retinoic acid receptor α and β genes. EMBO J 8: 429-433, 1989.
19. Houle B, Rochette-Egly C and Bradley WE: Tumor-suppressive effect ofthe retinoic acid receptor B in human epidermoid lung cancer cells. Proc Natl Acad Sci USA 90: 985-989, 1993.
20. Jing YK, Bleiweiss I, Brower S, Tarrter P, Waxman S and Mira-y-Lopez R: Retinoic acid receptor (RAR) beta induction and cell proliferation regulation by retinoic acids (RA) in human breast cancer. Proceedings of the American Association for Cancer Research 35: 1611, 1994.
21. Boylan JF, Lohnes D, Taneja R, Chambon P and Gudas LJ: Loss of retinoic acid receptor γ function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc Natl Acad Sci USA 90: 9601-9605, 1993.
22. Moasser MM, DeBlasio A and Dmitrovsky E: Response and resistance to retinoic acid are mediated through the retinoic acid receptor γ in teratocarcinoma cells. Proceedings of the American Association for Cancer Research 35: 544, 1994.
23. van der Burg B, van der Leede BM, Kwakkenbos-Isbrücker L, Salverda S, de Laat SW and van der Saag PT: Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol Cell Endocrinol 91: 149-157, 1993.
24. Giguere V: Retinoicacid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrine Rev 15: 61-79, 1994.
25. Dolle P, Ruberte E, Kastner P, Petkovich M, Stoner CM, Gudas LJ and Chambon P: Differential expression of genes encoding alpha, beta, and gamma retinoic acid receptors and CRABP in the developing limbs of the mouse. Nature 342: 702-705, 1989.
26. Boylan JF and Gudas LJ: Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiationspecific gene expression in F9 teratocarcinoma cells. J Cell Biol 112: 965-979, 1991.
27. Napoli JL: Retinol metabolism in LLC-PK1 cells. Characterization of retinoic acid synthesis by an established mammalian cell line. J Biol Chem 261: 13592-13597, 1986.
28. Vanden Bossche H, Willemsens G and Janssen PA: Cytochrome-P-450dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole. Skin Pharmacol 1: 176-185, 1988.
29. Gubler ML and Sherman MI: Metabolism of retinoic acid and retinol by intact cells and cell extracts. Methods Enzymol 189: 525-530, 1990.
30. Fogh K, Voorhees JJ and Astrom A: Expression, purification, and binding properties of human retinoic acid-binding protein type I and type II Arch Bioehem Biophys 300: 751-755, 1993